OptimizeRx Corporation
General ticker "OPRX" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $234.7M (TTM average)
OptimizeRx Corporation does not follow the US Stock Market performance with the rate: -17.0%.
Estimated limits based on current volatility of 1.8%: low 6.50$, high 6.73$
Factors to consider:
- Total employees count: 133 (+3.1%) as of 2025
- Top business risk factors: History of losses, Need for additional capital, Liquidity and credit risks, Seasonal trends, Development risks
- Current price 32.2% below estimated low
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [9.87$, 17.31$]
- 2026-12-31 to 2027-12-31 estimated range: [9.12$, 16.35$]
Financial Metrics affecting the OPRX estimates:
- Positive: with PPE of 12.5 at the end of fiscal year the price was low
- Positive: 6.62 < Operating cash flow per share per price, % of 7.86
- Positive: 7.57 < Operating profit margin, % of 10.69
- Negative: 0 < Inventory ratio change, % of 0.05
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: negative Industry operating income (median)
- Positive: Shareholder equity ratio, % of 72.52 > 64.23
Short-term OPRX quotes
Long-term OPRX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $71.52MM | $92.13MM | $109.43MM |
| Operating Expenses | $97.92MM | $105.83MM | $97.74MM |
| Operating Income | $-26.40MM | $-13.71MM | $11.69MM |
| Non-Operating Income | $1.24MM | $-5.68MM | $-4.74MM |
| Interest Expense | $1.45MM | $6.16MM | $5.29MM |
| Income(Loss) | $-25.16MM | $-19.39MM | $6.95MM |
| Taxes | $-7.60MM | $0.72MM | $1.82MM |
| Net Income(Loss)* | $-17.57MM | $-20.11MM | $5.13MM |
| Stockholders Equity | $126.55MM | $117.00MM | $128.29MM |
| Assets | $183.37MM | $171.17MM | $176.92MM |
| Operating Cash Flow | $-7.24MM | $4.89MM | $18.71MM |
| Capital expenditure | $0.87MM | $0.11MM | $0.06MM |
| Investing Cash Flow | $-25.34MM | $-0.45MM | $0.07MM |
| Financing Cash Flow | $28.22MM | $-4.91MM | $-8.80MM |
| Earnings Per Share** | $-1.03 | $-1.10 | $0.28 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.